Glossary of Hostile Takeover Terms with Discussion

What in the world would Pfizer want with Allergan? Taxes were it's sole purpose but if new tax breaks are given by Trump they would not even need Allergan for that reason!

 

Nothing. The days of $200 plus are gone. It's the "provebial hits the metal" and for
Good fairh, i am warning you. It will be ugly

 

There is no reason, Ichan dumped all
His shares. We are in uncharted waters and the truth is that this is a sinking ship. BS doesn't care about you and no one else does either. Earning call in February will
Describe the blood bath. Nothing more to say . It is what it is

 

December 27,2016
"According to the website MTNewswire, a class action lawsuit has been filed against Allergan PLC (AGN) with the United States District Court for the District of New Jersey. The lawsuit alleges AGN released materially false and misleading statements regarding its business, operational and compliance policies, and financial results." Valaent Lite?

Read more: Allergan Stock Showing Signs of Life (AGN) | Investopedia http://www.investopedia.com/news/allergan-stock-showing-signs-life-agn/#ixzz4U3rJCqGx
Follow us: Investopedia on Facebook

 

http://www.seekingalpha.com/article/4033332
This article is for you, Dan, and those if us you educated on the truth about Valaent and gave us a crash course on M&A these past few years. Hope you're Holidays are going well and bravo on calling a spade a spade!!
Thanks

 

The article is shit! Guy is a VRX short and Pharma is not in a bubble. As much as VRX is a doomed company, this article is a biased, opinion of one goof who shorts the stock. Nothing New that hasn't already been said and/or written already.

 

Dan,

What's your take on Valeant's Litigation Management Agreement?

Thanks!

 

I would love to hear everyone's thoughts on the SEC letter. If the article referenced above is correct, is it time to sell AGN stock?

I hope my fellow ex-AGN employees have recovered and settled into their new lives by now.

 

SEC finally criticizing the usage of non-GAAP earnings.

 

SEC finally cracking down on the way some companies report non-GAAP earnings.

 

True it is over but can't help but think of the devasting cost:

1. Legacy AGN and the specialty focus on unmet patient needs is gone. Legacy AGN products keep a much larger boat afloat and it is not the legacy AGN activities that are given priority.

2. The philosophy of a well funded and valued internal research balanced with outside acquisitions. Sometimes it seems we actually prefer "not made here" warts and all.

3. Loss of jobs.

4. Loss of a profitable American, California based company.

5. Loss of opportunity for those of us that are no longer based in a headquarters but rather take our commands from back east. Often little to no respect for legacy AGN opinion/expertise (note representation at bold awards, global/cross-site leadership positions, promotions). I am not saying legacy AGN are more qualified than others but are our qualifications so deficient relative to others to explain the lack of representation...seems hard to believe.

6. VRX employees 401k and security in their jobs.

7. Legacy company pipelines destroyed by VRX and those patient needs that will not be met anytime soon.

8......and much more....

Seeing what could have happened to AGN, it is hard not to see what a "blessing" the ACT acquisition was but make no mistake there is a fair argument to make regarding would it be better to have remained an independent company.

 

From someone who did lose their job after being a legacy AGN for over 25 years, there is no question in my mind that AGN would be performing much better with Pyott at the helm and being independent. Saunders has tried to project a growth Pharma model to Wall St and so far has failed miserably. The stock is down over 30% from it's all time highs and it's still to be seen whether it can reach even $250-260 by the end of 2017. This is a game between the good ole boys. Nothing more than money exchange for top brass while the rest of the employees suffer. Shareholders too! M &a A should be written in the business history books as the downfall of employee loyalty and pride in their jobs. In the event of mergers, the buying company should be obligated to contribute to all layer off workers their SS and Medicaid taxes at that employees last highest salary. Currently that's another ding on a layer employee! Your SS payout gets smaller if you don't find a comparable job with pay soon after layoffs. All right- I'm done bitching! I just hope Ackman falls of a cliff with Pearson soon!

 

I agree with all that has been said.

Allergan was an awesome place to work. Where I work now is also not bad by any stretch but I'm one of the luckier ones. Pharma in Southern California is pretty limited.

It is sad to see such a great research organization decimated by greed.

I hope that all have recovered by now as far as the many Allergan layoffs.

Ackman - I hope he falls off a cliff as well (but only after he goes bankrupt and has to eat a big serving of humble pie).

 

Dont forget the insider trading lawsuits - I hope whatever money ackamn and Pearson have left go to pay all the people they swindled

 

Thank you Dan for restoring my faith that sometimes if you have patience the bad guys lose! The management of PS/VRX were horrible so it seems just that they go down although like the AGN fiasco I am sure there will be a lot of innocent bystanders who lose too.

It will be good though to see that obnoxious ackman humbled through this ....